Does TELMISARTAN Cause Interstitial lung disease? 59 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 59 reports of Interstitial lung disease have been filed in association with TELMISARTAN (telmisartan). This represents 1.0% of all adverse event reports for TELMISARTAN.
59
Reports of Interstitial lung disease with TELMISARTAN
1.0%
of all TELMISARTAN reports
11
Deaths
27
Hospitalizations
How Dangerous Is Interstitial lung disease From TELMISARTAN?
Of the 59 reports, 11 (18.6%) resulted in death, 27 (45.8%) required hospitalization, and 5 (8.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 59 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which TELMISARTAN Alternatives Have Lower Interstitial lung disease Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS